4. Gene Therapy of Duchenne Muscular Dystrophy

Advances in Genetics

Volumn 35, Issue C, 1997, Pages 117-153

  Fassati, Ariberto ^a,b   Murphy, Stephen ^a   Dickson, George ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DYSTROPHIN;

ADENOVIRUS; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; CYTOLOGY; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; MALE; METABOLISM; METHODOLOGY; MOUSE; MUSCULAR DYSTROPHY; RETROVIRUS; REVIEW; SKELETAL MUSCLE; TRANSGENIC MOUSE; TRANSPLANTATION;

ADENOVIRIDAE; ANIMALS; DNA; DYSTROPHIN; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MALE; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHY, ANIMAL; RETROVIRIDAE;

EID: 0030633693     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2660(08)60449-6     Document Type: Article

References (217)

1. Abbs S., Roberts R.G., Mathew C.G., Bentley D.R., and Bobrow M.D. Accurate assessment of intragenic frequency within the Duchenne muscular dystrophy gene. Genomics 7 (1990) 602-606
2. Acsadi G., Dickson G., Love D.R., Jani A., Walsh F.S., Gurusinghe A., Wolff J.A., and Davies K.E. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature (London 352 (1991) 815-818
3. Acsadi G., Jani A., Huard A., Blaschuk K., Massie B., Holland P., Lochmüller H., and Kaparti G. Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants. Gene Therapy. 1 (1994) 338-340
4. Acsadi G., Massie B., and Jani A. Adenovirus-mediated gene transfer into striated muscles. J. Mol. Med. 73 (1995) 165-180
5. Acsadi G., Massie B., Simoneau M., Holland P., Blaschuk K., and Kaparti G. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet. 3 (1994) 579-584
6. Adams R.D., and Victor M. Principles of Neurology (1985), McGraw-Hill, New York
7. Ahn A.H., and Kunkel L.M. The structural and functional diversity of dystrophin. Nature Genet. 3 (1993) 283-291
8. Ahn A.H., and Kunkel L.M. Syntrophin binds to an alternatively spliced exon of dystrophin. J. Cell Biol. 128 (1995) 363-371
9. Akli S., Caillaud C., Vigne E., Stratford-Perricaudet L.D., Poenaru L., Perricaudet M., Kahn A., and Peschanski M.R. Transfer of a foreign gene into the brain using adenovirus vectors. Nat. Genet. 3 (1995) 224-228
10. Alameddine H.S., Quantin B., Cartaud A., Dehaupas M., Mandel J.L., and Fardeau M. Expression of a recombinant dystrophin in mdx mice using adenovirus vector. Neuromusc. Disord. 4 (1994) 193-203
11. Allbrook D. Skeletal muscle regeneration. Muscle Nerve 4 (1981) 234-245
12. Allen R.E., Merkel R.A., and Young R.B. Cellular aspects of muscle growth: Myogenic cell proliferation. J. Anim. Sci. 49 (1979) 115-127
13. Alton F.W.E.W., Middleton P.J., Caplen N.J., Smith S.N., Steel S., Munkonge F.M., Jeffrey P.K., Geddes D.M., Hart S.L., Williamson R., Fasold K.I., Miller A.D., Dickinson P., Stevenson B.J., McLachlan G., Dorin J.D., and Porteous D.J. Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat. Genet. 5 (1993) 135-142
14. Anderson J.E., Bressler B.H., and Ovalle W.K. Functional regeneration in the hindlimb skeletal muscle of the mdx mouse. J. Musc. Res. Cell. Motil. 9 (1988) 499-515
15. Anderson S.W., Routh D.K., and Ioasescu W. Serial position memory of boys with Duchenne muscular dystrophy. Dev. Med. Child. Neurol. 30 (1988) 328-333
16. Angelini C., Fanin M., Pegoraro E., Freda M.P., Cadaldini M., and Martinello F. Clinical-molecular correlation in 104 mild X-linked muscular dystrophy patients: Characterization of sub-clinical phenotypes. Neuromusc. Disord. 4 (1994) 349-358
17. Arahata K., Ishiura S., Ishiguro T., Tsukahara T., Suhara Y., Eguchi C., Ishihara T., Nonaka I., Ozawa E., and Sugita H. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature (London 333 (1988) 861-863
18. Arahata K., Ishihara T., Kamakura K., Tsukahara T., Ishiura S., Baba C., Matsumoto T., Nonaka I., and Sugita H. Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy. N. Engl. J. Med. 320 (1989) 138-142
19. Barnea E., Zuk D., Simantov R., Nudel U., and Yaffe D. Specificity of expression of the muscle and brain dystrophin gene promoters in muscle and brain cells. Neuron 5 (1990) 881-888
20. Barr E., and Leiden J.M. Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254 (1991) 1507-1509
21. Becker P.E., and Kiener F. Eine neue X-chromosomale Muskeldystrophie. Arch. Psych. Nervenkrank. 193 (1955) 427-448
22. Beggs A.H., Hoffman E.P., Snyder J.R., Arahata K., Specht L., Shapiro F., Angelini C., Sugita H., and Kunkel L.M. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: Dystrophin gene and protein studies. Am. J. Hum. Genet. 49 (1991) 54-67
23. Bett A.J., Haddara W., Prevec L., and Graham F.L. An efficient and flexible system for construction of adenovirus vectors with inserts or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91 (1994) 8802-8806
24. Bett A.J., Prevec L., and Graham F.L. Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol. 67 (1993) 5911-5921
25. Billard C., Gillet P., Signoret J.L., Uicaut E., Bertrand P., Fardeau M., Berthez-Carpentier M.A., and Santini J.J. Cognitive functions in Duchenne muscular dystrophy: A reappraisal and comparison with spinal muscular atrophy. Neuromusc. Disord. 2 (1992) 371-378
26. Bonilla E., Samitt C.E., Miranda A.F., Hays A.P., Salviati G., DiMauro S., Kunkel L.M., Hoffman E.P., and Rowland L.P. Duchenne muscular dystrophy: Deficiency of dystrophin at the muscle cell surface. Cell 54 (1988) 447-452
27. Bonilla E., Schmidt B., Samitt C.E., Miranda A.F., Hays A.P., DeOliveira A.B.S., Chang H.W., Servidei S., Ricci E., Younger D., and DiMauro S. Normal and dystrophin-deficient muscle fibres in carriers of the gene for Duchenne muscular dystrophy. Am. J. Pathol. 133 (1988) 440-445
28. Bout A., Imler J.L., Schultz H., Perricaudet M., Zurcher C., Herbrink P., Valerio D., and Pavirani A. In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: Efficacy, toxicity and safety. Gene Ther. 1 (1994) 385-394
29. Boyce F.M., Beggs A.H., Feener C., and Kunkel L.M. Dystrophin is transcribed in brain from a distant upstream promoter. Proc. Natl. Acad. Sci. USA 88 (1991) 1276-1280
30. Bulfield G., Siller W.G., Wight P.A.L., and Moore K.J. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA 81 (1984) 1189-1192
31. Byers T.J., Lidov H.G.W., and Kunkel L.M. An alternative dystrophin transcript specific to peripheral nerve. Nature Genet. 4 (1993) 77-80
32. Campbell K.P. Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage. Cell 80 (1995) 675-679
33. Carnwath J.W., and Shotton D.W. Muscular dystrophy in the mdx mouse: Histopathology of the soleus and extensor digitorum longus muscles. J. Neurol. Sci. 80 (1987) 39-54
34. Carpenter S., and Karpati G. Duchenne muscular dystrophy: Plasma membrane loss initiates muscle cell necrosis unless it is repaired. Brain 102 (1979) 147-161
35. Carpenter S., Karpati G., Zubrzycka-Gaarn E., Bulman D.E., Ray P.N., and Worton R.G. Dystrophin is localised to the plasma membrane of human skeletal muscle fibers by electron=microscopic cytochemical study. Muscle Nerve 13 (1990) 376-380
36. Celis and Celis. Construction and propagation of human adenovirus vectors. Cell Biology; A Laboratory Handbook 1 (1995), Academic Press, Aarhus, Denmark 479-490
37. Chamberlain J.S., Grant S.G., Reeves A.A., Mullins L.J., Stephenson D.A., Hoffman E.P., Monaco A.P., Kunkel L.M., Caskey C.T., and Chapman V.M. Regional localisation of the murine Duchenne muscular dystrophy gene on the mouse X chromosome. Som. Cell. Mol. Genet. 13 (1987) 671-678
38. Chamberlain J.S., Pearlman J.A., Muzny D.M., Gibbs R.A., Ranier J.E., Caskey C.T., and Reeves A.A. Expression of the murine Duchenne muscular dystrophy gene in muscle and brain. Science 239 (1988) 1416-1418
39. Chelly J., Kaplan J.-C., Maire P., Gautron S., and Kahn A. Transcription of the dystrophin gene in human muscle and non-muscle tissues. Nature 333 (1988) 858-860
40. Comi G.P., De Ciafaloni E., Silva R.H.A., Prelle A., Baardoni A., Rigoletto C., Robotti M., Bresolin N., Moggio M., Fortunato F., Ciscato P., Turconi A., Roses A.D., and Scarlato G.A. G + 1 → A transversion at the 5′ splice site of intron 69 of the dystrophin gene causing the absence of peripheral nerve Dp116 and severe clinical involvement in a DMD patient. Hum. Mol. Genet. 4 (1995) 2171
41. Cooper B.J., Gallagher E.A., Smith C.A., Valentine B.A., and Winand N.J. Mosaic expression of dystrophin in carriers of canine X-linked muscular dystrophy. Lab. Invest. 62 (1990) 171-178
42. Cooper B.J., Winand N.J., Stedman H., Valentine B.A., Hoffman E.P., Kunkel L.M., Scott M.-O., Fischbeck K.H., Kornegay J.N., Avery R.J., Williams J.R., Schmickel R.D., and Sylvester J.E. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 334 (1988) 154-156
43. Corrado K., Mills P.L., and Chamberlain J.S. Deletion analysis of the dystrophin-actin binding domain. FEBS Lett. 344 (1994) 255-260
44. Cosset F.L., Takeuchi Y., Morling F., Weiss R.A., Collins M.K.L., and Russell S. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J. Virol. 69 (1995) 6314-6322
45. Cox G.A., Cole N.M., Matsumura K., Phelps S.F., Hauschka S.D., Campbell K.P., Faulkner J.A., and Chamberlain J.S. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 364 (1993) 725-729
46. Cox G.A., Phelps S.F., Chapman V.M., and Chamberlain J.S. New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin. Nature Genet. 4 (1993) 87-93
47. Cox G.A., Sunada Y., Campbell K.P., and Chamberlain J.S. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nat. Genet. 8 (1994) 333-339
48. Cross R.A., Stewart M., and Kendrick-Jones J. Structural predictions for the central rod domain of dystrophin. FEBS Lett. 262 (1990) 87-92
49. Dai Y., Roman M., Naviaux R.K., and Verma I.M. Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. USA 89 (1992) 10892-10895
50. Danko I., Fritz J.D., Jiao S., Hogan K., Latendresse J.S., and Wolff J.A. Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Ther. 1 (1993) 114-121
51. Danko I., Fritz J.D., Latendresse J.S., Herweijer H., Schultz E., and Wolff J.A. Dystrophin expression improves myofiber survival in mdx muscle following intramuscular plasmid DNA injection. Hum. Mol. Gen. 2 (1994) 2055-2061
52. Davis H.L., Demeneix B.A., Quantin B., Coulombe J., and Whalen R.G. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum. Gene Ther. 4 (1993) 733-740
53. Davis H.L., and Jasmin B.J. Direct gene transfer into mouse diaphragm. FEBS. 333 (1993) 146-150
54. Davis H.L., Whalen R.G., and Demeneix B.A. Direct gene transfer into skeletal muscle in vivo: Factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4 (1993) 151-159
55. den Dunnen J.T., Grootscholten P.M., Bakker E., Blonden L.A.J., Ginjaar H.B., van Wapenaar M.C., van Passen H.M.B., Broeckhoven C., Pearson P., and van Ommen G.J.B. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am. J. Hum. Genet. 45 (1989) 835-847
56. Dhawan J., Pan L.C., Pavlath G.K., Travis M.A., Lanctot A.M., and Blau H.M. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254 (1991) 1509-1512
57. Dickson G., Love D.R., Davies K.E., Wells K.E., Piper T.A., and Walsh F.S. Human dystrophin gene transfer: Production and expression of a functional recombinant DNA-based gene. Hum. Genet. 88 (1991) 53-58
58. Duchenne G.B.A. Recherches sur la paralysie musculaire pseudohypertrophique ou paralysie myo-sclérosique. Arch. Gén. Méd. 11 (1868) 552-588 5-25; 179-209; 305-321; 421-443
59. Dunckley M.G., Love D.R., Davies K.E., Walsh F.S., Morris G.E., and Dickson G. Retro-viral-mediated transfer of a dystrophin minigene into mdx myoblasts in vitro. FEBS Lett 296 (1992) 128-134
60. Dunckley M.G., Wells D.J., Walsh F.S., and Dickson G. Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum. Mol. Genet. 2 (1993) 717-723
61. Dupont-Veersteegden E.E., and McCarter R.J. Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice. Muscle Nerve 15 (1992) 1105-1110
62. Edge M.B. Development of apposed sarcoplasmic reticulum at T system and sarcolemma and the change in orientation of triads in rat skeletal muscle. Dev. Biol. 23 (1970) 634-650
63. Emery A.E.H. Duchenne Muscular Dystrophy. 2nd Ed. (1993), Oxford University Press, Oxford
64. England S.B., Nicholson L.V.B., Johnson M.A., Forrest S.M., Love D.R., Zubrzycka-Gaarn E.E., Bulman D.E., Harris J.B., and Davies K.E. Very mild muscular dystrophy associated with deletion of 46% of dystrophin. Nature 343 (1990) 180-182
65. Ervasti J.M., and Campbell K.P. Membrane organisation of the dystrophin-glycoprotein complex. Cell 66 (1991) 1121-1131
66. Ervasti J.M., and Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell. Biol. 122 (1993) 809-823
67. Fassati A., Dunckley M.G., and Dickson G. Retroviral vectors. In: Dickson G. (Ed). Molecular and Cell Biology of Human Gene Therapeutics (1995), Chapman & Hall, London 1-19
68. Fassati A., Wells D.J., Walsh F.S., and Dickson G. Efficiency of in vivo gene transfer using murine retroviral vectors is strain-dependent in mice. Hum. Gene Ther. 6 (1995) 1177-1183
69. Fassati A., Wells D.J., Walsh F.S., and Dickson G. Transplantation of retroviral producer cells for in vivo gene transfer into mouse skeletal muscle. Hum. Gene Ther. 7 (1996) 595-602
70. Feener C.A., Koenig M., and Kunkel L.M. Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus. Nature 338 (1989) 509-511
71. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Northrop J.P., Ringold G.M., and Danielsen M. Lipofection: A highly efficient, lipid mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84 (1987) 7413-7417
72. Ferrari G., Salvatori G., Rossi C., Cossu G., and Mavilio F. A retroviral vector containing a muscle specific enhancer drives gene expression only in differentiated muscle fibers. Hum. Gene. Ther. 6 (1995) 733-742
73. Gilgenkrantz H., Hugnot J.-P., Lambert M., Chafey P., Kaplan J.-C., and Kahn A. Positive and negative regulatory DNA elements including a CCArGG box are involved in the cell type-specific expression of the human muscle dystrophin gene. J. Biol. Chem. 267 (1992) 10823-10830
74. Gooding L.R. Virus proteins that counteract host immune systems. Cell 71 (1992) 5-7
75. Gorecki D.C., Monaco A.P., Derry J.M., Walker A.P., Barnard E.A., and Barnard P.J. Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum. Mol. Genet. 1 (1992) 505-510
76. Graham F.L., Smiley J., Russel W.C., and Nairn R. Characterisation of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36 (1977) 59-72
77. Greenberg D.S., Sunada Y., Campbell K.P., Yaffe D., and Nudel U. Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice. Nat. Genet. 8 (1994) 340-344
78. Hemmings L., Kuhlman P.A., and Critchley D.R. Analysis of the actin-binding domain of alpha-actinin by mutagenesis and demonstration that dystrophin contains a functionally homologous domain. J. Cell. Biol. 116 (1992) 1369-1380
79. Hoffman E.P., Arahata K., Minetti C., Bonilla E., Rowland L.P., et al. Dystrophinopathy in isolated cases of myopathy in females. Neurology 42 (1992) 967-975
80. Hoffman E.P., Brown R.H., and Kunkel L.M. Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 51 (1987) 919-928
81. Hoffman E.P., Fischbeck K.H., Brown R.H., Johnson M., Medori R., Loike J.D., Harris J.B., Waterston R., Brooke M., Specht L., et al. Characterisation of dystrophin in muscle-biopsy specimens from patients with Duchenne's and Becker's muscular dystrophy. N. Engl. J. Med. 318 (1988) 1363-1368
82. Huard J., Acsadi G., Jani A., Massie B., and Karpati G. Gene transfer into skeletal muscle by isogenic myoblasts. Hum. Gene. Ther. 5 (1994) 949-958
83. Huard J., Roy R., Bouchard J.-P., Malouin F., Richards C.L., and Tremblay J.-P. Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant. Proc. 24 (1992) 3049-3051
84. Hugnot J.P., Gilgenkrantz H., Vincent N., Chafey P., Morris G.E., Monaco A.P., Berwald-Netter Y., Koulakoff A., Kaplan J.-C., Kahn A., and Chelly J. Distal transcript of the dystrophin gene initiated from an alternative first exon and encoding a 75kDa protein widely distributed in nonmuscle tissues. Proc. Natl. Acad. Sci. USA 89 (1992) 7506-7510
85. Ibraghimov-Beskrovnaya O., Ervasti J.M., Leveille C.J., Slaughter C.A., Sernett S.W., and Campbell K.P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355 (1992) 696-702
86. Jagadha V., and Becker L.E. Brain morphology in Duchenne muscular dystrophy: A golgi study. Pediatr. Neurol. 4 (1988) 87-92
87. Jiao S., Williams P., Berg R.K., Hodgeman B.A., Liu L., Repetto G., and Wolff J.A. Direct gene transfer into non-human primate myofibres in vivo. Hum. Gene Ther. 3 (1992) 21-33
88. Kawai S., and Nishizawa N. New procedures for DNA transfection with polycation and dimethyl sulfoxide. Mol. Cell Biol. 4 (1984) 1172-1174
89. Karagan N.J. Intellectual functioning in Duchenne muscular dystrophy: A review. Psychol. Bull. 86 (1979) 250-259
90. Karpati G., Ajdukovic D., Arnold D., Gledhill R.B., Guttman R., Holland P., Koch P.A., Shoubridge E., Spence D., Vanasse M., Watters G.V., Abrahamovicz M., Duff C., and Worton R.G. Myoblast transfer in Duchenne muscular dystrophy. Ann. Neurol. 34 (1993) 8-17
91. Karpati G., Zubrycka-Gaarn E., Carpenter S., Bulman D.E., Ray P.N., and Worton R.G. Age-related conversion of dystrophin negative to positive fiber segments of skeletal but not cardiac muscle fibers in heterozygote mdx mice. J. Neuropathol. Exp. Neurol. 2 (1990) 96-105
92. Kasahara N., Dozy A.M., and Kan Y.W. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266 (1994) 1373-1376
93. Kass-Eisler A., Falck-Pedersen E., Elfenbein D.H., Alvira M., Buttrick P.M., and Leiwand L.A. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1 (1994) 395-402
94. Kinoshita I., Vilquin J.T., Guerette B., Asselin I., Roy R., and Tremblay J.P. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 17 (1994) 1407-1415
95. Klamut H.J., Gangopadhyay S.B., Worton R.G., and Ray P.N. Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene. Mol. Cell. Biol. 10 (1990) 193-205
96. Koenig M., Beggs A.H., Moyer M., Scharpf S., Heindrich K., Bettecken T., Meng G., Muller C.R., Lindlof M., Kaariainen H., et al. The molecular basis for Duchenne versus Becker muscular dystrophy: Correlation of severity with type of deletion. Am. J. Hum. Genet. 45 (1989) 498-506
97. Koenig M., Monaco A.P., and Kunkel L.M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53 (1988) 219-228
98. Krahn M.J., and Anderson J.E. Anabolic steroid treatment increases myofiber damage in mdx mouse muscular dystrophy. J. Neurol. Sci. 125 (1994) 138-146
99. Kremer E.J., and Perricaudet M. Adenovirus and adeno-associated virus mediated gene transfer. Brit. Med. Bull. 51 (1995) 31-44
100. Law P.K. Beneficial effects of transplanting normal limb-bud mesenchime into dystrophic mouse muscles. Muscle Nerve 5 (1982) 619-627
101. Law P.K., Bertorini T.E., Goodwin T.E., Chen M., Fang Q., Li H.G., Kirby D.S., Florendo J.A., Herrod H.G., and Golden G.S. Dystrophin production by myoblasts transfer therapy in Duchenne muscular dystrophy. Lancet 14 (1990) 114-115
102. Law P.K., and Goodwin T.G. Genetic complementation of dystrophic muscles. Muscle Nerve 9 5s (1986) 235
103. Law P.K., and Yap J.L. New muscle transplant method produces normal twitch tension in dystrophic muscle. Muscle Nerve 2 (1979) 356-363
104. Lederfein D., Levy Z., Augier N., Mornet D., Morris G., Fuchs O., Yaffe D., and Nudel U. A 71 kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues. Proc. Natl. Acad. Sci. USA 89 (1992) 5346-5350
105. Lederfein D., Yaffe D., and Nudel U. A housekeeping type promoter, located in the 3′ region of the dystrophin gene, controls the expression of Dp71, a major product of the gene. Hum. Mol. Genet. 2 (1993) 1883-1888
106. Lemaire C., Heilig R., and Mandel J.-L. The chicken dystrophin cDNA: Striking conservation of the C-terminal coding and 3′ untranslated regions between man and chicken. EMBOJ. 7 (1988) 4157-4162
107. Levine B.A., Moir A.J.G., Patchell V.B., and Perry S.V. The interaction of actin with dystrophin. FEBS Lett. 263 (1990) 159-162
108. Levine B.A., Moir A.J.G., Patchell V.B., and Perry S.V. Binding sites involved in the interaction of actin with the N-terminal region of dystrophin. FEBS Lett. 298 (1992) 44-48
109. Lidov H.G.W., Byers T.J., and Kunkel L.M. The distribution of dystrophin in the murine central nervous system: An immunocytochemical study. Neuroscience 54 (1993) 167-187
110. Lidov H.G.W., Byers T.J., Watkins S.C., and Kunkel L.M. Localization of dystrophin to post-synaptic regions of central nervous system cortical neurons. Nature (London 348 (1990) 725-728
111. Lidov H.G.W., Selig S., and Kunkel L.M. Dp140: A novel 140 kDa CNS transcript from the dystrophin locus. Hum. Mol. Genet. 4 (1995) 329-335
112. Lipton B.H., and Schulz E. Developmental fate of skeletal muscle satellite cells. Science 205 (1979) 1292-1294
113. Love D.R., Flint T.J., Genet S.A., Middleton-Price H.R., and Davies K.E. Becker muscular dystrophy patient with large intragenic dystrophin deletion: Implications for functional minigenes and gene therapy. J. Med. Genet. 28 (1991) 860-864
114. Makover A., Zuk D., Breakstone J., Yaffe D., and Nudel U. Brain-type and muscle-type promoters of the dystrophin gene differ greatly in structure. Neuromusc. Disord. 1 (1991) 39-45
115. Mann R., Mulligan R.C., and Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper free defective retrovirus. Cell 33 (1983) 153-159
116. Mannino R.J., and Gould-Fogerite S. Liposome-mediated gene transfer. Biotechniques 6 (1988) 682-690
117. Matis L.A., and Rollins S.A. Complement-specific antibodies: Designing novel anti-inflammatories. Nat. Med. 8 (1995) 839-842
118. 2-terminal and rod domains of dystrophin. J. Clin. Invest. 93 (1994) 99-105
119. Matsumura K., Nonaka I., Tomé F.M.S., Arahata K., Collin H., Leturcq F., Récan D., Kaplan J.-C., Fardeau M., and Campbell K.P. Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having in-frame deletions in the rod domain of dystrophin. Am. J. Hum. Genet. 53 (1993) 409-416
120. Matsumura K., Tome F.M.S., Collin H., Azibi K., Chaouch M., Kaplan J.-C., Fardeau M., and Campbell K.P. Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy. Nature 359 (1992) 320-322
121. Matsumura K., Tomé F.M.S., Ionasescu V., Ervasti J.M., Anderson R.D., Romero N.B., Simon D., Récan D., Kaplan J.-C., Fardeau M., and Campbell K.P. Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin. J. Clin. Invest. 92 (1993) 866-871
122. Melacini P., Fanin M., Danieli G.A., Fasoli G., Villanova C., Angelini C., Vitiello L., Miorelli M., and Buja G.F. Cardiac involvement in Becker muscular dystrophy. J. Am. Coll. Cardiol. 22 (1993) 1927-1934
123. Miller D.G., Adam M.A., and Miller A.D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10 (1990) 4239-4242
124. Mirabella M., Servidei S., Manfredi G., Ricci E., Frustaci A., Bertini E., Rana M., and Tonali P. Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophy. Neurology 43 (1993) 2342-2345
125. Mitani K., Graham F.L., Caskey C.T., and Kochanek S. Rescue and propagation, and partial purification of a helper-dependent adenovirus vector. Proc. Natl. Acad. Sci. USA 92 (1995) 3854-3858
126. Miyashita H., Ikeda U., Shimada K., Natsume T., and Arahata K. Becker muscular dystrophy with early manifestation of left heart failure. Int. Med. 32 (1993) 408-411
127. Mokri B., and Engel A.G. Duchenne dystrophy: Electron microscopic findings pointing to a basic defect or early abnormality in the plasma membrane of the muscle fibre. Neurology 25 (1975) 1111-1120
128. Monaco A.P., Bertelson C.J., Liechti-Gallati S., Moser H., and Kunkel L.M. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2 (1988) 90-95
129. Monaco A.P., Neve R.L., Colletti-Feener C., Bertelson C.J., Kurnitt D.M., and Kunkel L.M. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323 (1986) 646-650
130. Montgomery R.D. Growth of human striated muscle. Nature 195 (1962) 194-195
131. Morgan J.E., Watt D.J., Sloper J.C., and Partridge T.A. Partial correction of an inherited biochemical defect of skeletal muscle by grafts of normal muscle precursor cells. J. Neurol. Sci. 86 (1988) 137-147
132. Morgan J.E., Hoffman E.P., and Partridge T.A. Normal myogenic cells form newborn mice restore normal histology to degenerating muscles of the mdx mouse. J. Cell. Biol. 111 (1990) 2437-2449
133. Moss F.P. The relationship between the dimensions of the fibers and the number of nuclei during restricted growth of skeletal muscle. Am. J. Anat. 122 (1968) 565-572
134. Moss F.P. The relationship between the dimensions of the fibers and the number of nuclei during normal growth of skeletal muscle in the domastic fowl. Am. J. Anat. 122 (1968) 555-564
135. Muntoni F., Cau M., Ganau A., Cogiu R., Arvedi G., Mateddu A., Marrosu M.G., Cianchetti C., Realdi G., Cao A., and Melis M.A. Brief report: Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N. Engl. J. Med. 329 (1993) 921-925
136. Naffakh N., Pinset C., Montarras D., Pastoret C., Danos O., and Heard J.M. Transplantation of adult-derived myoblasts in mice following gene transfer. Neuromusc. Disord. 3 (1994) 413-417
137. v integrins. Trends Cell Biol. 4 (1994) 52-55
138. Nicholson L.V.B. The "rescue" of dystrophin synthesis in boys with Duchenne muscular dystrophy. Neuromusc. Disord. 3 (1993) 525-531
139. Nishio H., Takeshima Y., Narite N., Yanagawa H., Suzuki Y., Ishikawa Y., Ishikawa Y., Minami R., Nakamura H., and Matsuo M. Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter. J. Clin. Invest. 94 (1994) 1037-1042
140. Nudel U., Robzyk K., and Yaffe D. Expression of the putative Duchenne muscular dystrophy gene in differentiated cell cultures and in the brain. Nature 331 (1988) 635-638
141. Oudet C., Hanamer A., Clemens P., Caskey T., and Mandel J.-L. Two hotspots of recombination in the DMD gene correlate with the deletion prone regions. Hum. Mol. Genet. 1 (1992) 599-603
142. Oudet C., Heiling R., Hanauer A., and Mandel J.L. Non-radioactive assay for new microsatellite polymorphism at the 5′ end of the dystrophin gene and estimation of intragenic recombination. Am. J. Hum. Genet. 49 (1991) 311-319
143. Partridge T.A., Grounds M., and Sloper J.C. Evidence of fusion between host and donor myoblasts in skeletal muscle grafts. Nature 273 (1978) 306-308
144. Partridge T.A., Morgan J.E., Coulton G.R., Hoffman E.P., and Kunkel L.M. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337 (1989) 176-179
145. Passos-Bueno M.R., Vainzof M., Marie S.K., and Zatz M. Half the dystrophin gene is apparently enough for a mild clinical course: Confirmation of its potential use for gene therapy. Hum. Mol. Genet. 3 (1994) 919-922
146. Pasternak C., Wong S., and Elson E. Mechanical function of dystrophin in muscle cells. J. Cell. Biol. 128 (1995) 355-361
147. Pegoraro E., Schimke R.N., Garcia C., Stern H., Cadaldini M., Angelini C., Barbosa E., Carroll J., Marks W.A., Neville H.E., Marks H., Appleton S., Toriello H., Wessel H.B., Donnelly J., Bernes S.M., Taber J.W., Weiss L., and Hoffman E.P. Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: Evidence for failure of dystrophin production in dystrophin competent myonuclei. Neurology 45 (1995) 677-690
148. Perricaudet M., and Stratford-Perricaudet L.D. Ch1. Adenovirus-mediated in vivo gene therapy. In: Vos J.M.H. (Ed). Viruses in Human Gene Therapy (1995), Chapman and Hall, London 1-32
149. Petrof B.J., Shrager J.B., Stedman H.H., Kelly A.M., and Sweeney H.L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA 90 (1993) 3710-3714
150. Phelps S.F., Hauser M.A., Cole N.M., Rafael J.A., Faulkner J.A., and Chamberlain J.S. Prevention of muscular dystrophy by full-length and internally truncated dystrophins. Hum. Mol. Genet. 4 (1995) 1251-1258
151. Piccolo G., Azan G., Tonin P., Arbustini E., Gavazzi A., Banfi P., Mora M., MOrandi L., and Tedeschi S. Dilated cardiomyopathy requiring cardiac transplantation as initial manifestation of Xp21 Becker type muscular dystrophy. Neuromusc. Disord. 4 (1994) 143-146
152. Pillers D.-A.M., Bulman D.E., Weleber R.G., Sigesmund D.A., Musarella M.A., Powell B.R., Murphey W.H., Westall C., Panton C., Becker L.E., Worton R.G., and Ray P.N. Dystrophin expression in the human retina is required for normal function as defined by electroretinography. Nature Genet. 4 (1993) 82-86
153. Prosser E.J., Murphy E.G., and Thompson M.W. Intelligence and the gene for Duchenne muscular dystrophy. Arch. Dis. Child. 44 (1989) 221-230
154. Quantin B., Perricaudet L.D., Tajakhsh S., and Mandel J.L. Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl. Acad. Sci. USA 89 (1992) 2581-2584
155. Ragot T., Vincent N., Chafey P., Vigne E., Gilgenkrantz H., Couton D., Cartaud J., Briand P., Kaplan J.C., Perricaudet M., and Kahn A. Efficient adenovirus-mediated transfer of a human mini-dystrophin gene to skeletal muscle of mdx mice. Nature (London 361 (1993) 647-650
156. Roberts R.G., Bardy T.F.M., Manners E., Bobrow M., and Bentley D.R. Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am. J. Hum. Genet. 49 (1991) 298-310
157. Roberts R.G., Bobrow M., and Bentley D.R. Point mutations in the dystrophin gene. Proc. Natl. Acad. Sci. USA 89 (1992) 2331-2335
158. Roberts R.G., Coffey A.J., Bobrow M., and Bentley D.R. Exon structure of the human dystrophin gene. Genomics 16 (1993) 536-538
159. Roberts R.G. Dystrophin, its gene and the dystrophinopathies. Adv. Genet. 33 (1995) 177-231
160. Rosman N.P. The cerebral defect and myopathy in Duchenne muscular dystrophy: A comparative clinicopathological study. Neurology 20 (1970) 324-335
161. Rother R.P., Squinto S.P., Mason J.M., and Rollins S.A. Protection of retroviral vector particles in the human blood through complement inhibition. Hum. Gen. Ther. 6 (1995) 429-435
162. Salvatori G., Ferrari G., Mezzogiorno A., Servidei S., Coletta M., Tonali P., Giavazzi R., Cossu G., and Mavilio F. Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo. Hum. Gene Ther. 4 (1993) 713-722
163. Sato O., Nonomura Y., Kimura S., and Maruyama K. Molecular shape of dystrophin. J. Biochem. 112 (1992) 631-636
164. Schofield J.P., and Caskey C.T. Non-viral approaches to gene therapy. Brit. Med. Bull. 51 (1995) 56-71
165. Sharp N.J.H., Kornegay J.N., VanCamp S.D., Herbstreith M.H., Secore S.L., Kettle S., Hung W.-Y., Constantinou C.D., Dykstra M.J., Roses A.D., and Bartlett R.J. An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics 13 (1992) 115-121
166. Sicinski P., Geng Y., Ryder-Cook A.S., Barnard E.A., Darlison M.G., and Barnard P.J. The molecular basis of muscular dystrophy in the mdx mouse: A point mutation. Science 244 (1989) 1578-1580
167. Smith B.F., Hoffman R.K., Giger U., and Wolfe J.H. Genes transferred by retrovirus vectors into normal and mutant myoblasts in primary cultures are expressed in myotubes. Mol. Cell. Biol. 10 (1990) 3268-3271
168. Somia N.V., Zoppe M., and Verma I.M. Generation of targetted retroviral vectors by using a single-chain Varidde fragments-an approach to in vivo delivery. Proc. Natl. Acad. Sci. USA 16 (1995) 7570-7574
169. Stedman H.H., Sweeney H.L., Shrager J.B., Maguire H.C., Panettieri R.A., Petrof B., Narusawa M., Leferovich J.M., Sladky J.T., and Kelly A.M. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352 (1991) 536-539
170. Sunada Y., Bernier S.M., Kozak C.A., Yamada Y., and Campbell K.P. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin to M chain to dy locus. J. Biol. Chem. 269 (1994) 13729-13732
171. Suzuki A., Yoshida M., Hayashi K., Mizuno Y., Hagiwara Y., and Ozawa E. Molecular organisation at the glycoprotein complex-binding site of dystrophin: Three dystrophin-associated proteins bind directly to the carboxyl-terminal portion of dystrophin. Eur. J. Biochem. 220 (1994) 283-292
172. Suzuki A., Yoshida M., and Ozawa E. Mammalian α1 and β1 syntrophin bind to the alternative splice-prone region of the dystrophin COOH terminus. J. Cell. Biol. 128 (1995) 373-381
173. Suzuki A., Yoshida M., Yamamoto H., and Ozawa E. Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain. FEBS Lett. 308 (1992) 154-160
174. Takeshima Y., Nihio H., Sakamoto H., Nakamura H., and Matsuo M. Modulation of in vitro splicing of the upstream intron by modifying an intraexon sequence which is deleted from the dystrophin gene in dystrophin Kobe. J. Clin. Invest. 95 (1995) 515-520
175. Takeuchi Y., Cosset F.L., Lachmann P.J., Okada H., Weiss R.A., and Collins M.K.L. Type-C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J. Virol. 68 (1994) 8001-8007
176. Tennyson C.N., Klamut H.J., and Worton R.G. The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced. Nat. Genet. 9 (1995) 184-190
177. Tinsley J.M., Blake D.J., and Davies K.E. Apo-dystrophin-3: A 2.2kb transcript from the DMD locus encoding the dystrophin glycoprotein binding site. Hum. Mol. Genet. 2 (1993) 521-524
178. Tome F.M.S., Evangelista T., Leclerc A., Sunada Y., Manole E., Estournet B., Barois A., Campbell K.P., and Fardeau M. Congenital muscular dystrophy with merosin deficiency. CR Acad. Sci. (Paris 317 (1994) 351-357
179. Top F.H., Bueschier E.L., Bancroft W.H., and Russell P.K. Immunisation with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J. Invest. Dis. 124 (1971) 155-160
180. Tracey I., Scott R.B., Campbell H.T., Dunn J.F., Barnes P.R.J., Styles P., Kemp G.J., Rae C.D., Pike M., and Radda G.K. Brain abnormalities in Duchenne-muscular dystrophy: Phosphorous-31 magnetic resonance spectroscopy and neuropsychological study. Lancet 345 (1995) 1260-1264
181. Tremblay J.P., Bouchard J.P., Theau D., Cotrell F., Collin H., Richards C.I., Malouin F., Tome F.M.S., and Fardeau M. Tranplantation de myoblastes entre des jumelles monozygotiques porteuse de la dystrophie musculaire de Duchenne. Resume des Communications, V colloque Nationale sur les Maladies Neuromusculaires (1993), Strasbourg, France 301
182. Tremblay J.P., Malouin F., Roy R., Huard J., Bouchard J.P., Satoh A., and Richards C.L. Results of a triple blind clinical study of myoblasts transplantation without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant. 2 (1993) 99-112
183. Trivedi R.A., and Dickson G. Liposome mediated gene transfer into normal and dystrophin-deficient mouse myoblasts. J. Neurochem. 64 (1995) 2230-2238
184. Uchino M., Miike T., Iwashita H., Uyama E., Yoshioka K., Sugino S., and Ando M. PCR and immunoblot analysis of dystrophin in Becker muscular dystrophy. J. Neurol. Sci. 124 (1994) 225-229
185. Vainzof M., Passos-Bueno M.R., Takata R.I., Pavanello R.C.M., and Zatz M. Intrafamilial variability in dystrophin abundance correlated with difference in the severity of the phenotype. J. Neurol. Sci. 119 (1993) 39-42
186. Valentine B.A., Cooper B.J., Cummings J.F., and DeLahunta A. Canine X-linked muscular dystrophy: Morphologic lesions. J. Neurol. Sci. 97 (1990) 1-23
187. Varmus H. Form and function of retroviral proviruses. Science 216 (1982) 812-820
188. Vilquin J.-T., Asselin I., Guerette B., Kinoshita I., Roy R., and Tremblay J.P. Successful myoblast allotransplantation in mdx mice using rapamycin. Transplantation 59 (1995) 422-426
189. Vincent N., Ragot T., Gilenkrantz H., Couton D., Chafey P., Grégoire A., Briand P., Kaplan J.C., Kahn A., and Perricaudet M. Long term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a mini-dystrophin gene. Nat. Genet. 5 (1993) 130-134
190. Vincent N., Ragot T., Gilgenkrantz H., Couton D., Chafey P., Grégoire A., Briand P., Kaplan J.-C., Kahn A., and Perricaudet M. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat. Genet. 5 (1993) 130-134
191. Vittadiello M., Schaffino M.V., Picard A., Scarpa M., and Schiaffino S. Gene transfer in regenerating muscle. Hum. Gene Ther. 5 (1994) 11-18
192. Wagner E., Zatloukal K., Cotten M., Kirlappos H., Mechtler K., Curiel D.T., and Birnstiel M.L. Coupling of adenovirus to transferrin-polylysine/DNA complexex greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. USA 89 (1992) 6099-6103
193. Watkins S.C., Hoffman E.P., Slayter H.S., and Kunkel L.M. Dystrophin distribution in heterozygote mdx mice. Muscle Nerve 12 (1989) 861-868
194. Watt D.J., Morgan J.E., and Partridge T.A. Use of mononuclear precursor cells to insert allogenic genes into growing mouse muscles. Muscle Nerve 7 (1984) 741-750
195. Weiss R., Teich N., Varmus H., and Coffin J. RNA Tumor Viruses (1985), Cold Spring Harbor Press, New York
196. Wells D.J. Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscle. FEBS Lett. 332 (1993) 179-182
197. Wells D.J., and Goldspink G. Age and sex influence expression of plasmid DNA directly into mouse skeletal muscle. FEBS Lett. 306 (1992) 203-205
198. Wells D.J., Wells K.E., Asante E.A., Turner G., Sunada Y., Campbell K.P., Walsh F.S., and Dickson G. Expression of human full-length and minidystrophin in transgenic mdx mice: Implications for gene therapy of Duchenne muscular dystrophy. Hum. Mol. Genet. 4 (1995) 1245-1250
199. Wells D.J., Wells K.E., Walsh F.S., Davies K.E., Goldspink G., Love D.R., Chan-Thomas P., Dunckley M.G., Piper T., and Dickson G. Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice. Hum. Mol. Genet. 1 (1992) 35-40
200. Welsh R.M., Cooper N.R., Jensen F.C., and Oldstone M.B.A. Human serum lyses RNA tumour viruses. Nature 257 (1975) 612-614
201. 5 promote adenovirus internalisation but not virus attachment. Cell 73 (1993) 309-319
202. White J.M. Integrins as virus receptors. Curr. Biol. 3 (1993) 596-599
203. Williams P.E., and Goldspink G. Longitudinal growth of striated muscle fibers. J. Cell Sci. 9 (1971) 751-767
204. Wolff J.A., Dowty M.E., Jiao S., Repetto G., Berg R.K., Williams P., and Slautterback D.B. Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and cavaolae of mammalian skeletal muscle. J. Cell Sci. 103 (1992) 1249-1259
205. Wolff J.A., Ludtke J.J., Acsadi G., Williams P., and Jani A. Long term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Gen. 1 (1992) 363-369
206. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., and Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science 247 (1990) 1465-1468
207. Wolff J.A., Williams P., Acsadi G., Jiao S., Jani A., and Wang C. Conditions affecting direct gene transfer into rodent muscle in vivo. Biotechniques 11 (1991) 474-485
208. Worton R. Muscular dystrophies: Diseases of the dystrophin-glycoprotein complex. Science 270 (1995) 755-756
209. Wu G.Y., Wilson J.M., and Wu G.Y. Targetting genes: Delivery and persistent expression of a foreign gene driven by mammalian regulatory elements. J. Biol. Chem. 269 (1989) 16985-16987
210. Yang Y., Li Q., Ertl H.C.J., and Wilson J. Cellular and humoural immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69 (1995) 2004-2015
211. Yang Y., Nunes F.A., Berensci K., Furth E.E., Gönczol E., and Wilson J.M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91 (1994) 4407-4411
212. Yang Y., Nunes F.A., Berensci K., Gönczol E., Engelhardt J.F., and Wilson J.M. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy for cystic fibrosis. Nat. Genet. 7 (1994) 362-369
213. Yao S.-N., and Kurachi K. Implanted myoblasts not only fuse with myofibers but also survive as muscle precursor cells. J. Cell. Sci. 105 (1993) 957-963
214. Yei S., Mittereder N., Te K., Sullivan O.'C., and Trapnell B.C. Adenovirus-mediated gene transfer for cystic fibrosis: Quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther. 1 (1994) 192-200
215. Zabner J., Petersen D.M., Puga A.P., Graham S.M., Couture L.A., Keyes L.D., Lukason M.J., George St., Gregory J.A.R.J., Smith A.E., and Welsh M.J. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat. Genet. 6 (1994) 75-83
216. Zatz M., Rapaport D., Vainzof M., et al. Serum creatine kinase (CK) and pyruvate kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy. J. Neurol. Sci. 102 (1991) 190-196
217. Zhu N., Liggitt D., Liu Y., and Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science 261 (1993) 209-211